State Street
OM icon

State Street’s Outset Medical OM Stock Holding History

State Street’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$351K Sell
81,206
-253,788
-76% -$1.11M ﹤0.01% 3676
2026
Q1 		$1.29M Buy
334,994
+4,860
+1% +$19.9K ﹤0.01% 3430
2025
Q4 		$1.22M Sell
330,134
-1,602
-0.5% -$13.7K ﹤0.01% 3475
2025
Q3 		$4.68M Buy
331,736
+126,466
+62% +$1.97M ﹤0.01% 3016
2025
Q2 		$3.94M Buy
205,270
+189,809
+1,228% +$2.96M ﹤0.01% 3043
2025
Q1 		$171K Buy
15,461
+2,796
+22% +$33.3K ﹤0.01% 3863
2024
Q4 		$211K Sell
12,665
-313
-2% -$3.91K ﹤0.01% 3842
2024
Q3 		$132K Sell
12,978
-1,034
-7% -$30.8K ﹤0.01% 3925
2024
Q2 		$809K Sell
14,012
-53,286
-79% -$2.61M ﹤0.01% 3497
2024
Q1 		$2.24M Sell
67,298
-1,955
-3% -$99K ﹤0.01% 3241
2023
Q4 		$5.62M Sell
69,253
-30,768
-31% -$2.5M ﹤0.01% 2892
2023
Q3 		$16.3M Buy
100,021
+7,394
+8% +$1.75M ﹤0.01% 2290
2023
Q2 		$30.4M Buy
92,627
+5,797
+7% +$1.77M ﹤0.01% 1969
2023
Q1 		$24M Buy
86,830
+8,652
+11% +$3.18M ﹤0.01% 2102
2022
Q4 		$30.3M Sell
78,178
-5,474
-7% -$1.54M ﹤0.01% 1960
2022
Q3 		$20M Buy
83,652
+6,031
+8% +$1.61M ﹤0.01% 2226
2022
Q2 		$17.3M Buy
77,621
+6,712
+9% +$2.89M ﹤0.01% 2354
2022
Q1 		$48.3M Buy
70,909
+1,043
+1% +$628K ﹤0.01% 1790
2021
Q4 		$48.3M Buy
69,866
+902
+1% +$667K ﹤0.01% 1823
2021
Q3 		$51.1M Buy
68,964
+7,309
+12% +$4.98M ﹤0.01% 1798
2021
Q2 		$46.2M Buy
61,655
+38,891
+171% +$29.7M ﹤0.01% 1906
2021
Q1 		$18.6M Buy
22,764
+12,361
+119% +$9.54M ﹤0.01% 2402
2020
Q4 		$8.87M Buy
+10,403
New +$8.02M ﹤0.01% 2699

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

State Street's OM Position: Q2 2026 in Review

State Street reduced its Outset Medical (OM) stake by 76% in Q2 2026, selling an estimated $1.11M and leaving 81,206 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #3676.

State Street first reported a position in OM in Q4 2020 and has held it in 23 quarters since. The position peaked at $51.1M in Q3 2021. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • State Street held 81,206 shares of Outset Medical worth $351K as of Q2 2026.
  • State Street sold 253,788 Outset Medical shares in Q2 2026, an estimated $1.11M.
  • Outset Medical made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3676 holding.
  • State Street first reported a position in Outset Medical in Q4 2020 and has held it in 23 quarters since.
  • State Street's Outset Medical position peaked at $51.1M in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.